Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition

NCT01603173 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Fasting State

Interventions

DRUG: Quetiapine Fumarate Tablets 25 mg
DRUG: Quetiapine Fumarate

Sponsor

IPCA Laboratories Ltd.